Interestingly, high expression of DCAF4L1 is associated with a decreased probability for survival in kidney cancer patients and an increased probability in the case of bladder cancer (TCGA Consortium, http://timer.cistrome.org [43], Figs S3A and S4A). The gene discussed is DCAF4L1; the disease is urinary bladder carcinoma.